A new monoclonal antibody treatment, benralizumab, offers hope for the millions living with severe asthma. This targeted therapy could significantly reduce the need for high-dose steroid treatments, which carry significant health risks.
Affecting around 5% of asthma patients, severe asthma causes debilitating symptoms like chest tightness, coughing, and anxiety. High-dose steroids are the mainstay of treatment, but they come with serious side effects like diabetes, osteoporosis, and adrenal suppression.
Benralizumab works differently. By targeting specific immune cells called eosinophils, it effectively reduces inflammation without the harmful side effects of steroids.
A recent clinical trial involving over 200 patients showed remarkable results. A staggering 92% of participants were able to safely reduce their steroid intake, with over 60% completely eliminating their dependence on them.
This breakthrough offers a safer and potentially life-changing alternative for severe asthma sufferers, improving their quality of life and reducing the long-term health risks associated with steroid use.
Professor David Jackson, the head of the Severe Asthma Centre at Guy's and St Thomas' and a Professor of Respiratory Medicine at King's College London, spearheaded the research that was published in The Lancet.
Professor Jackson said, "Biological therapies such as benralizumab have revolutionized severe asthma care in many ways, and the results of this study show for the first time that steroid-related harm can be avoided for the majority of patients using this therapy."
Featured Video Of The Day
Dark Truth Behind House Compensations In This Madhya Pradesh District
US Scientists Decode 125-Year-Old Element That Could Improve Cancer Treatments This "Miraculous Drink" Can Keep Acidity At Bay Struggling With PCOS? Balance Your Hormones With These 5 Supplements INDIA's Bihar Ally Mukesh Sahani's Father Brutally Murdered At Home Meet Indian-Origin Usha Chilukuri Vance, Wife Of Trump's Vice President Pick "Regret To Inform...": Trainee IAS Officer's Disability Request Was Denied Man, 65, Who Quit Job, Drained Savings To Start Business, Now A Billionaire JD Vance, Once A Donald Trump Critic, Now His Vice President Pick: 5 Facts Patient Stuck In Kerala Hospital's Lift For 1.5 Days, 3 Staffers Suspended Track Latest News Live on NDTV.com and get news updates from India and around the world.